Ainsworth Sean bought IRD

April 20, 2026 · Form 4 insider transaction

Ainsworth Sean bought 24,367 shares of Opus Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
24,367
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 20, 2026
Filing dateApril 22, 2026
Shares owned after321,692
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

View the original Form 4 on SEC EDGAR